Gurjit Kambo analyst JPMORGAN

Currently out of the existing stock ratings of Gurjit Kambo, 13 are a BUY (26%), 18 are a HOLD (36%), 19 are a SELL (38%).

Gurjit Kambo

Work Performance Price Targets & Ratings Chart

Analyst Gurjit Kambo, currently employed at JPMORGAN, carries an average stock price target met ratio of 47.48% that have a potential upside of 36.9% achieved within 194 days. Previously, Gurjit Kambo worked at JEFFERIES.

Gurjit Kambo’s has documented 93 price targets and ratings displayed on 7 stocks. The coverage is on Healthcare, Technology sectors.

Most recent stock forecast was given on HR, Healthcare Realty Trust at 16-Feb-2023.

Wall Street Analyst Gurjit Kambo

Analyst best performing recommendations are on EQ (EQUILLIUM).
The best stock recommendation documented was for HR (HEALTHCARE REALTY TRUST) at 2/23/2022. The price target of $16.27 was fulfilled within 5 days with a profit of $1.78 (9.86%) receiving and performance score of 19.72.

Average potential price target upside

EUXTF Euronext N.V EQ Equillium HR Healthcare Realty Trust ICG Intchains Group American Depositary Shares IT Gartner SLF Sun Life Financial AMD Advanced Micro Devices

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 03-Oct-2022

$102.29

$-62.51 (-37.93%)

$89.42

3 years 7 months 12 days ago
(13-Feb-2023)

2/2 (100%)

$27.12 (36.08%)

559

Buy Since 12-Oct-2020

$94.26

$-63.64 (-40.30%)

3 years 7 months 12 days ago
(13-Feb-2023)

9/9 (100%)

$19.09 (25.40%)

886

Buy Since 18-Oct-2022

$105.73

$-59.07 (-35.84%)

$92.04

3 years 9 months 13 days ago
(12-Dec-2022)

6/6 (100%)

$38.28 (56.75%)

804

Buy Since 20-May-2021

$101.7

$-63.1 (-38.29%)

4 years 4 months 9 days ago
(16-May-2022)

2/2 (100%)

$35 (52.47%)

1217

Buy Since 09-Apr-2020

$122.43

$-35.47 (-22.46%)

$134.83

4 years 7 months 18 days ago
(07-Feb-2022)

6/6 (100%)

$38.31 (45.54%)

820

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Gurjit Kambo?

On 2018
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?